send to a friend by email

JPH posts net income of $1.47 million at the end of 2014

2015-02-16

According to Jerusalem Pharmaceuticals Company JPH’s consolidated data for year-end preliminary financial statements for year 2014, net profit after tax reached 1,467,177 USD, compared with a net profit after tax of 2,248,123 USD in the audited data for 2013, a net decrease of 34.7%. Total assets of the company reached 54,192,782 USD as of December 31st, 2014, compared to total assets of 53,934,080 USD as of December 31st, 2013, a net increase of 0.5%. Total liabilities of the company reached 18,700,744 USD as of December 31st, 2014, compared to total liabilities of 16,876,326 USD as of December 31st, 2013, a net increase of 10.8%. Net ownership equity of the company reached 35,492,038 USD (including 361,607 USD in Non-controlling interest) as of December 31st, 2014, compared with a net ownership equity of 37,057,754 USD (including 705,854 USD in Non-controlling interest) as of December 31st, 2013, a net decrease of 4.2%.